Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 25, 2025
Distalmotion Completes First US Sale of its DEXTER® Robotic Surgery System to Memorial Hermann Health System
GlobeNewswire
·
March 25, 2025
Lausanne, Switzerland, March 25, 2025 (GLOBE NEWSWIRE) -- Distalmotion announces that it completed the first US sale and delivery of the DEXTER Robotic Surgery System to Memorial Hermann Health System in Houston, Texas in early February. This milestone …
Helicore Biopharma Announces First Participant Dosed in Phase 1 Clinical Trial of HCR-188, a First-in-Class GIP Antagonist for the Treatment of Obesity
GlobeNewswire
·
March 25, 2025
Helicore’s first-in-human study is designed to evaluate the safety and tolerability of HCR-188 in a single and multiple ascending dose study Top-line safety data anticipated in the second half of 2025 SOUTH SAN FRANCISCO, Calif., March 25, 2025 (GLOBE …
LiveWorld Reports 2024 Financial Results
GlobeNewswire
·
March 25, 2025
CAMPBELL, Calif. and NEW YORK , March 25, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for the year 2024. Twelve Months 2024 Financial and Business Highlights Total twelve months revenues of $11.3 million, …
Emerald Isle Health & Recovery Announces New Chief Executive Officer
GlobeNewswire
·
March 25, 2025
SUN CITY, Ariz., March 25, 2025 (GLOBE NEWSWIRE) -- Emerald Isle Health …
Marius Pharmaceuticals Strengthens IP Portfolio with New KYZATREX® (testosterone undecanoate) CIII Capsules Formulation Patent
GlobeNewswire
·
March 25, 2025
RALEIGH, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announced today that the United States Patent and Trademark Office (USPTO) has issued …
Digital Utilities Ventures Acquires Lifestyle Dock Company, and Expands Market Reach for Easy NanoVoid™ Technology
GlobeNewswire
·
March 25, 2025
Key Highlights: Strategic Acquisition for Market Expansion: Digital Utilities Ventures (OTC: DUTV) acquires Lifestyle Dock Company (LDC), unlocking a potential $3.4 million in additional revenue and expanding the reach of its patented Easy NanoVoid™ water …
Mangoceuticals Expands into $33 Billion Addressable Diabetes Market Through its Exclusive Rights to Market and Sell Patented and Clinically Proven Diabetinol® in the USA and Canada
GlobeNewswire
·
March 25, 2025
Diabetinol® is a clinically supported and patented plant-based nutraceutical product targeting the pre-diabetic and weight loss marketplace DALLAS, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company …
PathAI Showcases AI-Powered Pathology Innovations at the United States and Canadian Academy of Pathology (USCAP) 114th Annual Meeting
GlobeNewswire
·
March 25, 2025
BOSTON, March 25, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology solutions, today announced its participation in the United States and Canadian Academy of Pathology (USCAP) 114th Annual Meeting, taking place March 22–27, 2025, in …
Oncotelic Therapeutics Announces Successful Completion of Phase 1 Trial of OT-101 and IL-2, Highlights Findings at SWCR 2025 Conference
GlobeNewswire
·
March 25, 2025
AGOURA HILLS, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), ”), a leader in RNA-based therapeutics, announced today the successful completion of a Phase 1 clinical trial …
Genelux Corporation Announces Pricing of $10.5 Million Underwritten Offering of Common Stock
GlobeNewswire
·
March 25, 2025
WESTLAKE VILLAGE, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten offering of 3,000,000 shares of its common stock at …
NervGen Pharma to Host Virtual Investor Event
GlobeNewswire
·
March 25, 2025
VANCOUVER, British Columbia, March 25, 2025 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced that it will host a virtual investor …
Central Lab Services Market worth US$8.18 billion by 2030 with 6.5% CAGR | MarketsandMarkets™
GlobeNewswire
·
March 25, 2025
Delray Beach, FL, March 25, 2025 (GLOBE NEWSWIRE) -- The global Central Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR of 6.5%, reaching US$5.97 billion in 2025 and an impressive US$8.18 billion by 2030. The …
Epilepsy Foundation of America Harnesses the “Power in Purple” for Special Awareness Day
GlobeNewswire
·
March 25, 2025
BOWIE, Md., March 25, 2025 (GLOBE NEWSWIRE) -- Join the Epilepsy Foundation of America for Purple Day® on March 26, 2025 to uplift the “Power In Purple”, this year’s event theme. Approximately 65 million people are living with epilepsy across the world, …
Genelux and Newsoara Announce Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer
GlobeNewswire
·
March 25, 2025
– Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial responders. All participants with disease control experienced a reduction in all target lesions, with one participant …
Eterna Therapeutics Changes Name to Ernexa Therapeutics to Reflect New Strategic Focus on Ovarian Cancer and Autoimmune Disease
GlobeNewswire
·
March 25, 2025
Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing product development New tagline to emphasize the company’s unwavering commitment to patient impact, “Breaking …
NKGen Biotech To Present Updated Troculeucel Data at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
GlobeNewswire
·
March 25, 2025
SANTA ANA, Calif., March 25, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …
Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data
GlobeNewswire
·
March 25, 2025
Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in patients with mild-to-moderate Alzheimer’s disease Simufilam continued to demonstrate an overall favorable safety profile Cassava’s …
SCIENTURE Announces Commercial Operations Leadership and Strategic Agreement with Syneos Health, a leading Contract Sales Organization
GlobeNewswire
·
March 25, 2025
TAMPA, FL, March 25, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers …
Morningside Ventures Makes Strategic Investment in Xealth to Accelerate Digital Health Ecosystem
GlobeNewswire
·
March 25, 2025
BOSTON and SEATTLE, March 25, 2025 (GLOBE NEWSWIRE) -- Xealth, the leader in digital health enablement for health systems, today announced a strategic investment from Morningside Ventures, a leading investor in healthcare innovation. This investment will …
PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference
GlobeNewswire
·
March 25, 2025
PRINCETON, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced …